Coronavirus - we're here to help
From how to access your account online, scam awareness, your wellbeing and our community we're here to help.

Skip to main content
  • Register
  • Help
  • Contact us
  • Log in to HL Account

Cello Health plc (CLL) Ordinary 10p

Sell:160.00p Buy:162.00p 0 Change: No change
Market closed Prices as at close on 11 August 2020 Prices delayed by at least 15 minutes | Switch to live prices |
Bid situation | Shareholder Meeting

Cello Health plc Ordinary 10p

Type:
Shareholder Meeting
Shareholder action required:
Yes
Status:
Cash due
Details (last updated 17 Jul 2020)

Cello Health plc is seeking shareholder approval for a (recommended) cash acquisition by Pharma Value Demonstration Bidco Limited (a newly incorporated company wholly owned by Value Demonstration UK Holdings Limited), who have offered 161p for each Cello Health plc share held.

 

You can vote

 

The Scheme is subject to shareholder approval at shareholder meetings being held on 3 August 2020 and court approval at a hearing to be held on 7 August 2020. To vote please submit your instruction below before our noon Wednesday 29 July 2020 deadline.

 

The Scheme will be approved if shareholders who represent a majority in number and hold at least 75% in the value of the shares voted, vote in favour. If it’s approved, all shareholders on record at close of business on the 10 August 2020 will receive cash in place of their shares irrespective of if or how they voted. You will be able to trade your Cello Health plc shares until market close on 10 August 2020. Proceeds are expected to be paid on or shortly after 25 August 2020.

 

Full details of this event will be sent to Qualifying Hargreaves Lansdown clients by either post or secure message. Please note that any instruction you give must be based on the full details provided in the letter and not on the summary information outlined above.

×
Sell:160.00p
Buy:162.00p
Change: No change
Market closed Prices as at close on 11 August 2020 Prices delayed by at least 15 minutes | Switch to live prices |
Bid situation | Shareholder Meeting

Cello Health plc Ordinary 10p

Type:
Shareholder Meeting
Shareholder action required:
Yes
Status:
Cash due
Details (last updated 17 Jul 2020)

Cello Health plc is seeking shareholder approval for a (recommended) cash acquisition by Pharma Value Demonstration Bidco Limited (a newly incorporated company wholly owned by Value Demonstration UK Holdings Limited), who have offered 161p for each Cello Health plc share held.

 

You can vote

 

The Scheme is subject to shareholder approval at shareholder meetings being held on 3 August 2020 and court approval at a hearing to be held on 7 August 2020. To vote please submit your instruction below before our noon Wednesday 29 July 2020 deadline.

 

The Scheme will be approved if shareholders who represent a majority in number and hold at least 75% in the value of the shares voted, vote in favour. If it’s approved, all shareholders on record at close of business on the 10 August 2020 will receive cash in place of their shares irrespective of if or how they voted. You will be able to trade your Cello Health plc shares until market close on 10 August 2020. Proceeds are expected to be paid on or shortly after 25 August 2020.

 

Full details of this event will be sent to Qualifying Hargreaves Lansdown clients by either post or secure message. Please note that any instruction you give must be based on the full details provided in the letter and not on the summary information outlined above.

×
Sell:160.00p
Buy:162.00p
Change: No change
Market closed Prices as at close on 11 August 2020 Prices delayed by at least 15 minutes | Switch to live prices |
Bid situation | Shareholder Meeting

Cello Health plc Ordinary 10p

Type:
Shareholder Meeting
Shareholder action required:
Yes
Status:
Cash due
Details (last updated 17 Jul 2020)

Cello Health plc is seeking shareholder approval for a (recommended) cash acquisition by Pharma Value Demonstration Bidco Limited (a newly incorporated company wholly owned by Value Demonstration UK Holdings Limited), who have offered 161p for each Cello Health plc share held.

 

You can vote

 

The Scheme is subject to shareholder approval at shareholder meetings being held on 3 August 2020 and court approval at a hearing to be held on 7 August 2020. To vote please submit your instruction below before our noon Wednesday 29 July 2020 deadline.

 

The Scheme will be approved if shareholders who represent a majority in number and hold at least 75% in the value of the shares voted, vote in favour. If it’s approved, all shareholders on record at close of business on the 10 August 2020 will receive cash in place of their shares irrespective of if or how they voted. You will be able to trade your Cello Health plc shares until market close on 10 August 2020. Proceeds are expected to be paid on or shortly after 25 August 2020.

 

Full details of this event will be sent to Qualifying Hargreaves Lansdown clients by either post or secure message. Please note that any instruction you give must be based on the full details provided in the letter and not on the summary information outlined above.

×
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.
Open:
n/a
Trade high:
n/a
Year high:
163.50p
Market capitalisation
Market cap.
:
£171.77 million
Previous close:
161.00p
Trade low:
n/a
Year low:
101.00p
P/E ratio:
16.89
Previous:
0.00p (0.00%)
Previous:
0.00p
Volume:
n/a
Dividend yield:
1.34%
EMS:
3,000
Data delayed by at least 15 minutes.

Performance

Not available for this stock.

Fundamental data

Year ending: 31/12/2019 31/12/2018
Revenue (£m) 166.77 158.95
Profit before tax (£m) 7.11 9.38
Adjusted EPS (p): 9.53 9.07
P/E ratio 14.10 12.20
PEG 2.80 0.90
EPS growth (%) 5.00 14.00

Values are quoted in the stock's local currency: British pound

All fundamental data

Recent dividends paid or declared by Cello Health plc:

Type Ex-div date Payment date Amount
2nd interim 23/04/2020 22/05/2020 1.00p
Interim 03/10/2019 01/11/2019 1.15p
Final 25/04/2019 24/05/2019 2.75p
Interim 04/10/2018 02/11/2018 1.10p
Final 03/05/2018 25/05/2018 2.45p

This data is provided by Digital Look. HL accepts no responsibility for its accuracy and you should independently check data before making any investment decision.

Full dividend history

Five years' total annual Cello Health plc dividends:

Financial
year end
Dividend
yield
Dividend
cover
Total dividend
paid
31/12/2019 1.60% 4.43 2.15p
31/12/2018 3.50% 2.36 3.85p
31/12/2017 2.60% 2.27 3.50p
31/12/2016 3.30% 2.55 3.40p
31/12/2015 3.20% 3.05 2.86p

All dividend data is calculated excluding any special dividends. Historical dividends may be adjusted to reflect any subsequent rights issues and corporate actions.

Full dividend history

Ready to invest?

To buy shares in , you'll need to have an account. Try our handy filter to explore the different options.

Compare accounts

Ready to take your first step?

To invest in , you'll need to open an account.
Try our handy filter to find which one suits you best.

Compare accounts

Important Documents

There are no documents available for this stock.

Broker forecasts

Due to changes in how we source investment data, Broker Forecasts are not available. We're sorry for any inconvenience this may cause.

Recent trade data is unavailable. We will be replacing it, however in the meantime the information is available on the London Stock Exchange website.

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Prices provided by NBTrader. Charts provided by Factset. 'Broker forecast' and 'Recent trades' provided by MoneyAM. News and fundamental data provided by Digital Look.

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.